Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.
Anthera Pharmaceuticals Stock Down 100.0%
Anthera Pharmaceuticals Company Profile
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Further Reading
- Five stocks we like better than Anthera Pharmaceuticals
- How to Start Investing in Real Estate
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Stock Average Calculator
- Why Boeing May Be Ready to Take Off After Latest Developments
- How Technical Indicators Can Help You Find Oversold Stocks
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
